CD86-directed Antibody Interactions
- CD86-directed Antibody Interactions
- Accession Number
Drug Drug Description Belatacept A selective T-cell costimulation blocker used in the prophylaxis of organ rejection in adult patients receiving a kidney transplant. Abatacept A disease-modifying antirheumatic drug (DMARD) used for the management of moderate-to-severe active rheumatoid arthritis and active polyarticular juvenile idiopathic arthritis as monotherapy or in combination with other DMARDs.
- Drugs & Drug Targets
Drug Target Type Belatacept T-lymphocyte activation antigen CD86 target Belatacept T-lymphocyte activation antigen CD80 target Abatacept T-lymphocyte activation antigen CD80 target Abatacept T-lymphocyte activation antigen CD86 target